| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.960 | 175 | 0 | 1998 | 2020 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
phenotype | 0.100 | None | 0.975 | 162 | 1 | 1990 | 2020 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
phenotype | 0.100 | None | 0.975 | 159 | 0 | 1994 | 2020 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 156 | 1 | 2005 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.100 | None | 0.994 | 155 | 3 | 1997 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 0.981 | 154 | 0 | 1993 | 2020 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 148 | 1 | 2002 | 2020 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
phenotype | 0.100 | None | 0.993 | 140 | 0 | 2002 | 2020 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
phenotype | 0.100 | None | 0.979 | 140 | 0 | 2000 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 0.986 | 138 | 0 | 1995 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.100 | None | 0.977 | 131 | 0 | 2004 | 2020 | ||||||||
|
basigin (Ok blood group) | 0.458 | 0.769 | 2.6E-05 |
|
phenotype | 0.100 | None | 0.992 | 127 | 0 | 1993 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.984 | 126 | 0 | 1993 | 2020 | ||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
phenotype | 0.100 | None | 0.992 | 122 | 0 | 2010 | 2019 | |||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.100 | None | 0.983 | 118 | 2 | 1996 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.991 | 116 | 0 | 2003 | 2020 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
phenotype | 0.100 | None | 0.983 | 115 | 0 | 1993 | 2020 | ||||||||
|
plasminogen | 0.389 | 0.923 | 1.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 113 | 0 | 1983 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 0.972 | 108 | 1 | 1990 | 2019 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
phenotype | 0.100 | None | 0.991 | 107 | 0 | 2005 | 2019 | ||||||||
|
matrix metallopeptidase 7 | 0.446 | 0.885 | 1.0E-09 |
|
phenotype | 0.100 | None | 1.000 | 106 | 1 | 1993 | 2019 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
phenotype | 0.100 | None | 0.950 | 101 | 2 | 1995 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.990 | 101 | 0 | 1997 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.970 | 101 | 2 | 2004 | 2020 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
phenotype | 0.100 | None | 0.980 | 100 | 2 | 1997 | 2019 |